Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study
The DOI matches its Crossref record.
Abstract
Aim: to establish the effect of oral gabapentin on background, movement and referred pain in human subjects. Method: a randomised, double-blind, placebo controlled study of 80 adult patients with low back pain and associated referred leg pain. Baseline pain scores were measured; active treatment was with a dose of gabapentin increasing to 1200 mg daily over a six week period, the placebo group receiving an equal number of inactive capsules. 0-10 numerical pain scores were recorded daily throughout the study period (background, movement and referred pain), along with a measure of mobility and concomitant analgesic consumption. Results: 65 subjects provided results. There was no change in pain scores from baseline recordings to week 8 in terms of background pain. Gabapentin reduced referred pain by 0.45 after 8 weeks (p < 0.05) and movement pain by 0.47 (p < 0.05). There were no changes in mobility scores and analgesic consumption was only marginally reduced by use of gabapentin (0.45 tablets per day, p = 0.05). Conclusion: gabapentin in a dose increasing to 1200 mg per day has no effect on background pain and only a marginal effect on referred pain and pain on movement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
“Low-quality evidence showed no clear differences in adverse effects for ga-bapentin versus placebo (67, 68).”
BackgroundChou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
“Gabapentin is associated with small, short-term benefits in patients with radiculopathy (101, 102) and has not been directly compared with other medications or treatments.”
BackgroundChapter 4 European guidelines for the management of chronic nonspecific low back pain
Airaksinen, O., Brox, J. I., Cedraschi, C., Hildebrandt, J., Klaber-Moffett, J., Kovacs, F., Mannion, A. F., Reis, S., Staal, J. B., Ursin, H., et al. (2006) · European Spine Journal · doi:10.1007/s00586-006-1072-1 · Cited by 2,594
Chou, R., Deyo, R., Friedly, J., Skelly, A., Weimer, M., Fu, R., Dana, T., Kraegel, P., Griffin, J., & Grusing, S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2458 · Cited by 864
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Metadata
- Authors
- McCleane, G. J.
- Venue
- The Pain Clinic
- Publisher
- Informa UK Limited
- Published
- 2001-06
- Volume
- 13
- Issue
- 2
- Pages
- 103-107
- ISSN
- 0169-1112 (ISSN-L)
- 1568-5691
- OpenAlex
- W1985502152
- Cited by
- 56
- References
- 0
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study. https://app.cochat.ai/papers/10.1163/156856901753420945
- The paper
- McCleane, G. J. (2001). Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study. The Pain Clinic. https://doi.org/10.1163/156856901753420945
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.